Michael Carulli - Jan 5, 2024 Form 3 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Financial Officer
Signature
/s/ Robert Ticktin, by power of attorney
Stock symbol
PMVP
Transactions as of
Jan 5, 2024
Transactions value $
$0
Form type
3
Date filed
1/11/2024, 04:18 PM
Next filing
Jan 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PMVP Common Stock 9.07K Jan 5, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMVP Employee Stock Option (right to buy) Jan 5, 2024 Common Stock 24.6K $4.22 Direct F2
holding PMVP Employee Stock Option (right to buy) Jan 5, 2024 Common Stock 13.6K $28.33 Direct F3
holding PMVP Employee Stock Option (right to buy) Jan 5, 2024 Common Stock 27.2K $16.29 Direct F4
holding PMVP Employee Stock Option (right to buy) Jan 5, 2024 Common Stock 75K $5.70 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are represented by restricted stock units which vest on September 9, 2024.
F2 An option to purchase 28,489 shares was granted on June 2, 2020 and was exercised in part prior to the date on which the reporting person became subject to Section 16. One-fourth of the shares subject to the option vested on May 26, 2021, and the remaining shares vest in 36 equal monthly installments beginning on June 26, 2021.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
F4 Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.
F5 Shares subject to the option vest in 48 equal monthly installments beginning on June 12. 2023.